Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P450 11β-hydroxylase (CYP11B1) is a mitochondrial enzyme responsible for the final step in cortisol synthesis, converting 11-deoxycortisol to cortisol. It plays a crucial role in glucocorticoid production and is a therapeutic target for conditions involving cortisol excess or deficiency. Mutations in CYP11B1 can lead to congenital adrenal hyperplasia.
Inhibition of steroid 11-beta-hydroxylation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P450 11β-hydroxylase (CYP11B1).